In addition, the high expression of TYROBP in patients with renal cell carcinoma is associated with poor prognosis, suggesting that TYROBP may be involved in the occurrence and development of renal cell carcinoma and can be used as a target for diagnosis and treatment. Here, TYROBP is linked to hereditary clear cell renal cell carcinoma.